MedPath

Levofloxacin Kabi 5mg/mL Solution for Infusion

Registration Number: MAL16075025ARZ

Approved
Approval ID

5fa7dd15e3ce1ded

Registration Number

MAL16075025ARZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (6)

10*50ml mLAvailable
Package Size: 10*50ml mL
Status: NPRA Approved
1*50ml mLAvailable
Package Size: 1*50ml mL
Status: NPRA Approved
25*50ml mLAvailable
Package Size: 25*50ml mL
Status: NPRA Approved
1*100ml mLAvailable
Package Size: 1*100ml mL
Status: NPRA Approved
10*100ml mLAvailable
Package Size: 10*100ml mL
Status: NPRA Approved
25*100ml mLAvailable
Package Size: 25*100ml mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

LEVOFLOXACIN HEMIHYDRATEActive
Monograph: levofloxacin hemihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levofloxacin Kabi 5mg/mL Solution for Infusion - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform